Dapagliflozin and Insulin Resistance in Patients with Type 2 Diabetes

被引：0
|
作者：
Katz, Arie
Yeh, Helen
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1179-P
引用
收藏
页码：A304 / A305
页数：2
相关论文
共 50 条
  • [1] Efficacy and safety of dapagliflozin in patients with type 2 diabetes on insulin ± metformin regimens
    Yeh, H.
    Katz, A.
    DIABETOLOGIA, 2015, 58 : S357 - S357
  • [2] Efficacy and Safety of Dapagliflozin in Patients with Type 2 Diabetes on Insulin ± Metformin Regimens
    Katz, Arie
    Yeh, Helen
    DIABETES, 2015, 64 : A317 - A317
  • [3] Degree of ketonaemia and its association with insulin resistance after dapagliflozin treatment in type 2 diabetes
    Min, S. H.
    Oh, T. J.
    Baek, S. -I.
    Lee, D. -H.
    Kim, K. M.
    Moon, J. H.
    Choi, S. H.
    Park, K. S.
    Jang, H. C.
    Lim, S.
    DIABETES & METABOLISM, 2018, 44 (01) : 73 - 76
  • [4] Dapagliflozin in patients with type 2 diabetes mellitus
    Filippatos, Theodosios D.
    Liberopoulos, Evangelos N.
    Elisaf, Moses S.
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2015, 6 (01) : 29 - 41
  • [5] Dapagliflozin improves glycaemic control in insulin-resistant patients with type 2 diabetes
    Wilding, J. P. H.
    Norwood, P.
    T'joen, C.
    Bastien, A.
    List, J. F.
    Fiedorek, F. T.
    DIABETOLOGIA, 2009, 52 : S76 - S76
  • [6] Dapagliflozin as Additional Treatment to Liraglutide and Insulin in Patients With Type 1 Diabetes
    Kuhadiya, Nitesh D.
    Ghanim, Husam
    Mehta, Aditya
    Garg, Manisha
    Khan, Salman
    Hejna, Jeanne
    Torre, Barrett
    Makdissi, Antoine
    Chaudhuri, Ajay
    Batra, Manav
    Dandona, Paresh
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2016, 101 (09): : 3506 - 3515
  • [7] Effects of Goshajinkigan on insulin resistance in patients with type 2 diabetes
    Uno, T
    Ohsawa, I
    Tokudome, M
    Sato, Y
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2005, 69 (02) : 129 - 135
  • [8] Insulin resistance and carotid atherosclerosis in patients with type 2 diabetes
    Park, Seok Won
    Kim, Soo Kyung
    Cho, Yong-Wook
    Kim, Dae Jung
    Song, Young-Duk
    Choi, Young Ju
    Huh, Byung Wook
    Choi, Sung Hee
    Jee, Sun Ha
    Cho, Mi Ae
    Lee, Eun Jig
    Huh, Kap Bum
    ATHEROSCLEROSIS, 2009, 205 (01) : 309 - 313
  • [9] Use of dapagliflozin as an add-on to insulin therapy in patients with suboptimally controlled type 2 diabetes
    Das, Gautam
    Surya, Ashutosh
    Abusahmin, Hussam
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (08) : 269 - 270
  • [10] Dapagliflozin as Add-On Therapy in Asian Patients with Type 2 Diabetes Inadequately Controlled on Insulin
    Yang, Wenying
    Ma, Jianhua
    Li, Yiming
    Li, Yanbing
    Zhou, Zhiguang
    Kim, Jae Hyeon
    Zhao, June
    Ptaszynska, Agata
    DIABETES, 2017, 66 : A338 - A338
12345